Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT00940342 · COMPLETED
Trial details
- NCT number
- NCT00940342
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-12
- Primary completion
- 2017-01-05
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.